1.
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
2.
Financial care for the vulnerable: Rise and decline of Holland orphan chambers
Pharmaceutical compounding of orphan active ingredients in Belgium : how community and hospital pharmacists can address the needs of patients with rare diseases
Governance of conditional reimbursement practices in the Netherlands
Off-label use of orphan medicinal products: a Belgian qualitative study
3.
4.
Benevolent institutions. 1910.
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
5.
Bébée; Or, Two Little Wooden Shoes
Systematic review of available evidence on 11 high-priced inpatient orphan drugs
Taxonomic assignment of the ISU for the 334 PCR products (Table S3)